Agfa-Gevaert Past Earnings Performance
Past criteria checks 0/6
Agfa-Gevaert's earnings have been declining at an average annual rate of -1.9%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been declining at an average rate of 10.3% per year.
Key information
-1.9%
Earnings growth rate
-3.3%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | -10.3% |
| Return on equity | -8.9% |
| Net Margin | -2.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Agfa-Gevaert makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,126 | -32 | 315 | 70 |
| 30 Jun 24 | 1,129 | -31 | 322 | 70 |
| 31 Mar 24 | 1,130 | -48 | 324 | 69 |
| 31 Dec 23 | 1,150 | -53 | 329 | 73 |
| 30 Sep 23 | 1,865 | -209 | 418 | 97 |
| 30 Jun 23 | 1,163 | -190 | 347 | 82 |
| 31 Mar 23 | 1,875 | -233 | 440 | 103 |
| 31 Dec 22 | 1,145 | -184 | 358 | 82 |
| 30 Sep 22 | 1,497 | -73 | 386 | 88 |
| 30 Jun 22 | 1,463 | -60 | 370 | 85 |
| 31 Mar 22 | 1,788 | -16 | 402 | 94 |
| 31 Dec 21 | 1,760 | -17 | 395 | 95 |
| 30 Sep 21 | 1,743 | -22 | 399 | 95 |
| 30 Jun 21 | 1,713 | -44 | 391 | 97 |
| 31 Mar 21 | 1,670 | -106 | 377 | 95 |
| 31 Dec 20 | 1,709 | -106 | 385 | 95 |
| 30 Sep 20 | 1,771 | -149 | 408 | 98 |
| 30 Jun 20 | 1,848 | -137 | 427 | 99 |
| 31 Mar 20 | 1,948 | -83 | 451 | 101 |
| 31 Dec 19 | 1,975 | -89 | 457 | 103 |
| 30 Sep 19 | 1,990 | -44 | 457 | 112 |
| 30 Jun 19 | 2,042 | -35 | 475 | 119 |
| 31 Mar 19 | 2,104 | -37 | 490 | 131 |
| 31 Dec 18 | 2,191 | -21 | 507 | 141 |
| 30 Sep 18 | 2,287 | -3 | 519 | 140 |
| 30 Jun 18 | 2,341 | 15 | 521 | 143 |
| 31 Mar 18 | 2,404 | 36 | 528 | 144 |
| 01 Jan 18 | 2,443 | 37 | 532 | 144 |
| 30 Sep 17 | 2,467 | 46 | 542 | 145 |
| 30 Jun 17 | 2,499 | 56 | 545 | 145 |
| 31 Mar 17 | 2,522 | 68 | 545 | 143 |
| 31 Dec 16 | 2,537 | 70 | 543 | 141 |
| 30 Sep 16 | 2,545 | 75 | 542 | 140 |
| 30 Jun 16 | 2,581 | 83 | 542 | 141 |
| 31 Mar 16 | 2,627 | 68 | 546 | 143 |
| 31 Dec 15 | 2,646 | 62 | 551 | 144 |
| 30 Sep 15 | 2,685 | 74 | 559 | 146 |
| 30 Jun 15 | 2,660 | 50 | 557 | 147 |
| 31 Mar 15 | 2,620 | 53 | 548 | 147 |
| 31 Dec 14 | 2,620 | 50 | 544 | 146 |
| 30 Sep 14 | 2,648 | 72 | 508 | 145 |
| 30 Jun 14 | 2,701 | 58 | 556 | 143 |
| 31 Mar 14 | 2,782 | 53 | 526 | 142 |
| 31 Dec 13 | 2,865 | 41 | 581 | 146 |
Quality Earnings: AFGV.F is currently unprofitable.
Growing Profit Margin: AFGV.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AFGV.F is unprofitable, and losses have increased over the past 5 years at a rate of 1.9% per year.
Accelerating Growth: Unable to compare AFGV.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AFGV.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: AFGV.F has a negative Return on Equity (-8.89%), as it is currently unprofitable.